Yttrium-90 radioembolization for unresectable combined hepatocellular-cholangiocarcinoma
Cardiovascular and Interventional Radiology Aug 11, 2017
Chan LS, et al. – This study was undertaken to investigate the utility and safety of radioembolization with yttrium–90 microspheres for unresectable combined hepatocellular–cholangiocarcinoma (cHCC–CC). It was revealed that radioembolization with yttrium–90 microspheres considered as a safe and feasible treatment option for patients with unresectable cHCC–CC.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
